BC CANCER RESEARCH

What BC CANCER RESEARCH does

BC Cancer Research Institute (also operating as BCCRC or BC Cancer Research) is a Vancouver-headquartered, government-funded non-profit cancer research organization established in 1938 and operating under British Columbia's Provincial Health Services Authority (PHSA). The institute facilitates cancer research conducted by nationally and internationally recognized scientists across more than sixty laboratories throughout British Columbia, organized through twelve departments and programs: Office of Research Administration, Population Health Sciences, Terry Fox Laboratory, Molecular Oncology, Integrative Oncology, Lymphoid Cancer Research, Experimental Therapeutics, Clinical Research, Deeley Research Centre, Nursing Research, and Basic & Translational Research.

Core capabilities span basic biomedical research, genomics, clinical trials, health services research, cancer surveillance, and population health, supported by world-class platforms in genomics, bioinformatics, the Cancer Medical Imaging Core (CanMIC), experimental drug development (Experimental Therapeutics program), and tissue banking/biobanking. Active research areas include cancer genomics and precision medicine (anchored by Distinguished Scientist Dr. Marco Marra), lymphoma biology, immunotherapy (Deeley Research Centre), FLASH-radiotherapy and DNA damage response studies, nursing and health workforce research (anchored by Senior Scientist Dr. Leah Lambert), and population health. Operational sites span Vancouver (HQ at 675 West 10th Avenue), Kelowna, Abbotsford, and Prince George, with research findings disseminated through peer-reviewed journals, conferences (CANO/ACIO, CAHSPR, CCTG, BC Cancer Summit), and knowledge translation programs.

BC Cancer Research does not commercialize research outputs. Its funding is structured around four streams: (1) provincial government allocations through PHSA, (2) philanthropic donations channeled through the BC Cancer Foundation (the institute's fundraising partner, with all donations retained in BC), (3) competitive research grants from CIHR, Michael Smith Health Research BC, the Canadian Cancer Society, and the Terry Fox Research Institute, and (4) clinical trial partnerships with the Canadian Cancer Trials Group (CCTG). The go-to-market is community- and academic-led, relying on peer-reviewed publications, conferences, the KT Challenge and Research Challenge programs, and direct integration of research into BC Cancer's six regional cancer centres and multiple provincial screening programs. Customers/end-users are cancer patients across British Columbia, oncology clinicians and nursing workforce, researchers and trainees, and patient/family partners engaged in research co-design, with secondary relationships to academic institutions (UBC, UVic, UNBC) and four regional health authorities.

Name

BC CANCER RESEARCH

Legal name

BC Cancer Research Institute

Website

https://bccrc.ca

Company type

Private

Founded year

1938

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

BC Cancer Research Institute is a Vancouver-based, government-funded non-profit cancer research organization operating under British Columbia's Provincial Health Services Authority, conducting cancer research across 60+ labs and serving BC patients, clinicians, and researchers.

Ownership category

akta.pro rank

Product category

Cancer Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

akta.pro secondary industries

Molecular Tumor Boards & Clinical Interpretation Services (HLAAANAD), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

Keywords

• Cancer research
• Clinical trials
• Genomics research
• Biomedical research
• Nursing research

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Government Funding: Publicly funded research institution supported by provincial government through BC Cancer agency
2. Donations and Philanthropy: BC Cancer Foundation serves as fundraising partner, with every dollar staying in BC supporting world-leading research teams
3. Research Grants: Competitive research funding from agencies including Canadian Institutes of Health Research (CIHR), Michael Smith Health Research BC, Canadian Cancer Society, Terry Fox Research Institute
4. Clinical Trials: Funding from clinical trial participation and partnerships with Canadian Cancer Trials Group (CCTG)

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

BC Cancer Research conducts cancer control research spanning basic biomedical research, genomics, clinical trials, health services research, cancer surveillance, and population health across over sixty labs in British Columbia. The institute delivers research support services and platforms including genomics, bioinformatics, imaging, drug development, and tissue banking, while translating findings into personalized cancer care through BC Cancer's six regional centres. It also operates research-support programs such as the CNA Certification Award Program for oncology nurses, the Nursing and Allied Health Research Grant Competition, and the Knowledge Translation Challenge.

Product overview

BC Cancer Research Institute operates as a cancer research organization rather than a commercial product company. It facilitates research across multiple departments including basic biomedical research, genomics, clinical trials, health services research, cancer surveillance, population health, and innovative technology development. The organization provides research infrastructure and support services through various departments (Office of Research Administration, Population Health Sciences, Terry Fox Laboratory, Molecular Oncology, Integrative Oncology, Lymphoid Cancer Research, Experimental Therapeutics, Clinical Research, Deeley Research Centre, Nursing Research, and Basic & Translational Research) rather than packaged software products. Notable research support programs include the CNA Certification Award Program for oncology nurses, the Nursing and Allied Health Research Grant Competition, the Knowledge Translation Challenge, the Research Challenge, the Cancer Health Equity Collaborative (CHEC), and the BC Nursing Workforce Research Network.

Differentiator

Problem solved

Functional benefit

Products and services

• CNA Certification Award Program
• Nursing and Allied Health Research Grant Competition
• Knowledge Translation Challenge
• Cancer Health Equity Collaborative (CHEC)
• BC Cancer Clinical Trials Program
• BC Nursing Workforce Research Network

Quantifiable outcome

• Research initiatives address three priorities: improve equitable access to cancer care, integrate cancer research and care, stabilize and enhance the cancer care workforce

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Twelve partnerships are on record, tiered core and secondary.

• BC Cancer FoundationcoreGTM or Marketing PartnerBC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with donors, they are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care. Every dollar donated stays in BC supporting world-leading research teams.
• University of British Columbia (UBC)coreStrategic or Co-development PartnerStaff hold academic appointments in various programs at UBC's Vancouver and Okanagan campuses. Research collaborations span multiple departments including Medical Genetics, Interdisciplinary Oncology, Experimental Medicine, and School of Nursing. Dr. Leah Lambert is Clinical Associate Professor at UBC School of Nursing.
• Vancouver Coastal Health (VCH)coreStrategic or Co-development PartnerPractice-based research partner collaborating on KT Challenge program and various research initiatives. Dr. Kris Smith serves as Clinical Ethicist with Vancouver Coastal Health.
• Providence Health Care (PHC)coreStrategic or Co-development PartnerPractice-based research partner collaborating on KT Challenge program and knowledge translation initiatives.
• Fraser Health (FH)coreStrategic or Co-development PartnerPractice-based research partner collaborating on KT Challenge program supporting cancer care research.
• Northern Health (NH)coreStrategic or Co-development PartnerPractice-based research partner collaborating on KT Challenge program supporting equitable cancer care access.
• Canadian Cancer Trials Group (CCTG)coreStrategic or Co-development PartnerNational clinical trials group with which BC Cancer collaborates on clinical trials including ALC10 study for acute myeloid leukemia. BC Cancer-Kelowna IND240 team received CCTG IND Team Award.
• University of Victoria (UVic)secondaryStrategic or Co-development PartnerAcademic partner with research collaborations including Dr. Kelli Stajduhar's work. Dr. Kris Smith is a postdoctoral fellow at UVic's Institute on Aging and Lifelong Health.
• University of Northern British Columbia (UNBC)secondaryStrategic or Co-development PartnerAcademic partner institution listed in nursing research department collaborations.
• PHSA Patient & Family Partnerships and Experience TeamcoreStrategic or Co-development PartnerPatient and family engagement partners supporting research initiatives including Equity-Oriented Model of Care and Cancer Health Equity Collaborative (CHEC).
• BC Nurses' Union (BCNU)secondaryStrategic or Co-development PartnerUnion partner providing funding for Advance Care Planning research alongside MSHRBC and BC Cancer Foundation.
• Cancer Health Equity Collaborative (CHEC)coreStrategic or Co-development PartnerTeam of academic and health system partners focusing on developing strategies to improve equity within the cancer care sector. Investigators include Drs. Leah Lambert, Annette Browne, and Kelli Stajduhar.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Memorial Sloan Kettering Cancer Center: Major US cancer research and treatment institution with extensive genomics, precision oncology, and trial programs. Comparable as a leading broad-incumbent in cancer research with overlapping precision-medicine and trial capabilities.
• Dana-Farber Cancer Institute: US NCI-designated comprehensive cancer center with deep translational and clinical research programs. Comparable as a larger incumbent in academic cancer research with overlapping precision-medicine and trial portfolios.
• Fred Hutchinson Cancer Center: Large US NCI-designated cancer research center with strengths in immunology, genomics, and clinical trials. Comparable as a broader incumbent operating at much larger scale in the same translational cancer research space.

Direct peers

• University Health Network: Canadian academic health science network that houses Princess Margaret Cancer Centre. Comparable as a publicly funded Canadian academic health sciences organization with integrated research, education, and clinical care.
• Princess Margaret Cancer Centre: Major Canadian academic cancer research and treatment centre affiliated with University Health Network. Directly comparable as a Canadian cancer research hospital with integrated clinical, translational, and population health research.
• Canadian Cancer Trials Group: National cooperative clinical trials group coordinating cancer trials across Canada. Comparable as a clinical-trial infrastructure peer; BC Cancer is an active member and IND program trial site.
• Ontario Institute for Cancer Research: Canadian provincial cancer research institute conducting genomics, translational, and clinical research. Highly comparable as a sister public-sector cancer research organization of similar scope and scale.

Others

• Michael Smith Health Research BC: Provincial health research funding agency providing Scholar Awards and KT funding. Comparable as a key regional research-funder and capacity-building partner for BC-based investigators.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/bccancer
• Facebookfacebook.com/bccancer
• LinkedInlinkedin.com/company/bc-cancer
• Instagraminstagram.com/bccancer

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BC CANCER RESEARCH